I agree that this site is using cookies. You can find further informations here.
X
Castaño‐Diez, Sandra
27  results:
Search for persons X
?
1

Evaluation of European LeukemiaNet 2022 risk classification..:

Jiménez‐Vicente, Carlos ; Charry, Paola ; Castaño‐Diez, Sandra...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Characteristics and long‐term outcome in a large series of ..:

Castaño‐Díez, Sandra ; Pomares, Helena ; Esteban, Daniel...
British Journal of Haematology.  204 (2023)  3 - p. 892-897 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Acquired erythropoietic uroporphyria secondary to myeloid m..:

Serra‐García, Laura ; Morgado‐Carrasco, Daniel ; Pérez‐Valencia, Amanda Isabel...
Photodermatology, Photoimmunology & Photomedicine.  38 (2021)  1 - p. 86-91 , 2021
Link: https://doi.org/10.1111/..
 
?
4

Infrequent Presentations of Chronic NPM1-Mutated Myeloid Ne..:

Castaño-Díez, Sandra ; Guijarro, Francesca ; López-Guerra, Mònica...
Cancers.  16 (2024)  4 - p. 705 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Allogeneic hematopoietic cell transplantation with sequenti..:

Tolosa-Ridao, Carles ; Suárez-Lledó, María ; Jiménez-Vicente, Carlos...
Bone Marrow Transplantation.  , 2024
Link: https://doi.org/10.1038/..
 
?
6

PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH..:

Guardia-Torrelles, Ares ; Jimenez-Vicente, Carlos ; Roca, Alexandra Martínez...
HemaSphere.  7 (2023)  S3 - p. e32922f1 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Venetoclax with hypomethylating agents might lead to eradic..:

Jiménez-Vicente, Carlos ; Martínez-Roca, Alexandra ; Pomares, Helena...
Leukemia Research.  135 (2023)  - p. 107403 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Germ line variants in patients with acute myeloid leukemia ..:

Guijarro, Francesca ; López-Guerra, Monica ; Morata, Jordi...
Blood Advances.  7 (2023)  19 - p. 5799-5811 , 2023
Link: https://doi.org/10.1182/..
 
?
9

European LeukemiaNet 2017 risk stratification for acute mye..:

Bataller, Alex ; Garrido, Ana ; Guijarro, Francesca...
Blood Advances.  6 (2022)  4 - p. 1193-1206 , 2022
Link: https://doi.org/10.1182/..
 
?
10

MDS-472 STAG2 and SRSF2 Mutations Might Define Prognosis of..:

Toribio-Castelló, Sofía ; Castaño-Díez, Sandra ; Villaverde-Ramiro, Ángela...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S316-S317 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Poster: MDS-472 STAG2 and SRSF2 Mutations Might Define Prog..:

Toribio-Castelló, Sofía ; Castaño-Díez, Sandra ; Villaverde-Ramiro, Ángela...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S153 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Long-term outcomes in patients with relapsed/refractory acu..:

Guijarro, Francesca ; Bataller, Alex ; Diaz-Beyá, Marina...
Bone Marrow Transplantation.  57 (2022)  8 - p. 1304-1312 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Real-World Data on Chronic Myelomonocytic Leukemia: Clinica..:

Castaño-Díez, Sandra ; López-Guerra, Mónica ; Bosch-Castañeda, Cristina...
Cancers.  14 (2022)  17 - p. 4107 , 2022
Link: https://doi.org/10.3390/..
 
?
14

Risk Factors for Mortality in Hematopoietic Stem Cell Trans..:

Puerta-Alcalde, Pedro ; Chumbita, Mariana ; Charry, Paola...
Transplantation and Cellular Therapy.  27 (2021)  6 - p. 501.e1-501.e6 , 2021
Link: https://doi.org/10.1016/..
 
?
15

The avoidance of G-CSF and the addition of prophylactic cor..:

Rodríguez-Lobato, Luis-Gerardo ; Martínez-Roca, Alexandra ; Castaño-Díez, Sandra...
PLOS ONE.  15 (2020)  11 - p. e0241778 , 2020
Link: https://doi.org/10.1371/..
 
1-15